- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01460732
Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers
Home Versus Ambulatory Monitoring in the Assessment of the Diurnal Blood Pressure Profile and the Detection of Non-Dippers
This is a cross-sectional study, including adults, either untreated for hypertension, or under stable treatment for more than four weeks. Assessment will include:
Clinic blood pressure measurements with an automated oscillometric device, 24-hour ambulatory blood pressure monitoring Home blood pressure monitoring during morning, evening and nocturnal measurements with the same device.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Eligible patients, as described in Inclusion/Exclusion Criteria, will be instructed to use Microlife WatchBP Home-Nocturnal oscillometric device, in order to measure their BP two times with one-minute interval, in the morning between 6 and 9 am and in the evening between 6 and 9 pm respectively for six days. These six days shall be normal working days, selected be the patient, within a time-frame of two weeks approximately. Patients should be sitting for at least five minutes and calm. During three out of those six days, they will apply and activate the same device, in order to take BP measurements while they will be asleep. Those measurements are going to be taken automatically by the device, the first 2-hours after the activation and another two with one-hour interval. Measurements will be averaged as awake and asleep BP values, with a potential to derive, if so wished, separate averages of awake-morning and awake-evening BP values.
Microlife WatchBP O3 Ambulatory Blood Pressure Measurement (ABPM) device will be applied by a doctor to each patient and it will be removed the next day by a doctor. BP measurements will be performed every 20 minutes for 24 hours. BP measurements taken during awake and asleep hours for each patient, will be analyzed separately.
Additionally, triplicate sitting Clinic Blood Pressure measurements, with one-minute interval, will be performed with the Microlife WatchBP Home-Nocturnal device during each patient's visit at the Hypertension Center. Patients will visit Hypertension Center three times, one to apply the ABPM device and one to remove it and provide the Microlife WatchBP Home-Nocturnal device and another one to bring it back. This will take approximately two weeks.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Athens, Griekenland, 11527
- Sotiria General Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:ma
- Patients referred for high blood pressure
- Age over 30 years
- Untreated for hypertension or under stable treatment for 4 weeks or more
- Patients physically and mentally capable for self-measurement of blood pressure at home
- Written informed consent to participate in the study
Exclusion Criteria:
- Sustained arrythmia
- Pregnancy
- Symptomatic cardiovascular disease
- Any other serious disease (renal failure, heart failure, malignancy)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: All patients
All eligible patients in the study consist a single group and the same intervention is assigned to all of them.
|
Home Blood pressure Monitoring Nocturnal-Home Blood Pressure Monitoring Ambulatory Blood Pressure Monitoring
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Awake Systolic Home Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.
|
2 weeks
|
|
Awake Diastolic Home Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.
|
2 weeks
|
|
Asleep Systolic Home Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.
|
2 weeks
|
|
Asleep Diastolic Home Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.
|
2 weeks
|
|
Awake Systolic Ambulatory Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2 weeks
|
|
Awake Diastolic Ambulatory Blood Pressure Measurement
Tijdsspanne: 2 weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2 weeks
|
|
Asleep Systolic Ambulatory Blood Pressure Measurement
Tijdsspanne: 2weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2weeks
|
|
Asleep Diastolic Ambulatory Blood Pressure Measurement
Tijdsspanne: 2weeks
|
An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed.
Measurements taken during patient's awake and asleep hours are analyzed separately.
|
2weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Dippers Defined by ABPM and HBPM-Nocturnal
Tijdsspanne: 2 weeks
|
As Dippers are defined the patients who displayed a nocturnal fall (Daytime-Nighttime BP/Daytime BP) in Systolic and/or Diastolic Blood Pressure by 10% or more, by each method.
The rest of patients, with a nocturnal fall by less than 10% or even a rise of BP, are consequently defined as Non-Dippers.
|
2 weeks
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- NOCTURNAL
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Blood Pressure Monitoring
-
Mayo ClinicSnap40 Ltd.VoltooidOp afstand monitorenVerenigde Staten
-
Rush University Medical CenterNational Institute of Nursing Research (NINR); University of Illinois at Chicago en andere medewerkersVoltooidFysieke activiteitVerenigde Staten
-
Stryker InstrumentsVoltooidAnesthesie, generaalVerenigde Staten
-
Kuopio University HospitalVoltooidHartoperatieFinland
-
University of WashingtonWerving
-
University Hospital, GhentUniversity GhentBeëindigd
-
Liverpool University Hospitals NHS Foundation TrustKiActivVoltooidHartrevalidatieVerenigd Koninkrijk
-
National Taiwan University HospitalVoltooidCholangiopancreatografie, endoscopische retrograde | Endoscopische echografieTaiwan
-
Pacific Edge LimitedWervingUrotheliale blaaskankerVerenigde Staten, Australië
-
Neuralert Technologies LLCWerving